Literature DB >> 29782566

Post-operative radiation therapy in locally advanced non-small cell lung cancer and the impact of sequential versus concurrent chemotherapy.

Mark R Waddle1, Stephen Ko1, Margaret M Johnson2, Yanyan Lou3, Robert C Miller1, Anna C Harrell1, Daniel M Trifiletti1.   

Abstract

Entities:  

Year:  2018        PMID： 29782566      PMCID： PMC5943216          DOI： 10.21037/tlcr.2018.03.21

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  18 in total

1.  Effect of postoperative radiotherapy on outcome in resectable stage IIIA-N2 non-small-cell lung cancer: an updated meta-analysis.

Authors:  Nazmus Sakib; Na Li; Xiaoxia Zhu; Dianhe Li; Yiyi Li; Haofei Wang
Journal:  Nucl Med Commun       Date:  2018-01       Impact factor: 1.690

2.  Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small-Cell Lung Cancer.

Authors:  Elyn H Wang; Christopher D Corso; Charles E Rutter; Henry S Park; Aileen B Chen; Anthony W Kim; Lynn D Wilson; Roy H Decker; James Byunghoon Yu
Journal:  J Clin Oncol       Date:  2015-06-22       Impact factor: 44.544

3.  Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.

Authors:  Brian E Lally; Daniel Zelterman; Joseph M Colasanto; Bruce G Haffty; Frank C Detterbeck; Lynn D Wilson
Journal:  J Clin Oncol       Date:  2006-06-12       Impact factor: 44.544

4.  Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.

Authors:  Walter J Curran; Rebecca Paulus; Corey J Langer; Ritsuko Komaki; Jin S Lee; Stephen Hauser; Benjamin Movsas; Todd Wasserman; Seth A Rosenthal; Elizabeth Gore; Mitchell Machtay; William Sause; James D Cox
Journal:  J Natl Cancer Inst       Date:  2011-09-08       Impact factor: 13.506

5.  Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.

Authors:  Stephen G Chun; Chen Hu; Hak Choy; Ritsuko U Komaki; Robert D Timmerman; Steven E Schild; Jeffrey A Bogart; Michael C Dobelbower; Walter Bosch; James M Galvin; Vivek S Kavadi; Samir Narayan; Puneeth Iyengar; Clifford G Robinson; Raymond B Wynn; Adam Raben; Mark E Augspurger; Robert M MacRae; Rebecca Paulus; Jeffrey D Bradley
Journal:  J Clin Oncol       Date:  2016-10-31       Impact factor: 44.544

Review 6.  Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update.

Authors:  Mark G Kris; Laurie E Gaspar; Jamie E Chaft; Erin B Kennedy; Christopher G Azzoli; Peter M Ellis; Steven H Lin; Harvey I Pass; Rahul Seth; Frances A Shepherd; David R Spigel; John R Strawn; Yee C Ung; Michael Weyant
Journal:  J Clin Oncol       Date:  2017-04-24       Impact factor: 44.544

7.  Reduced toxicity with three-dimensional conformal radiotherapy or intensity-modulated radiotherapy compared with conventional two-dimensional radiotherapy for esophageal squamous cell carcinoma: a secondary analysis of data from four prospective clinical trials.

Authors:  J-Y Deng; C Wang; X-H Shi; G-L Jiang; Y Wang; Y Liu; K-L Zhao
Journal:  Dis Esophagus       Date:  2015-12-10       Impact factor: 3.429

8.  Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung.

Authors: 
Journal:  N Engl J Med       Date:  1986-11-27       Impact factor: 91.245

9.  Adjuvant radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline.

Authors:  George Rodrigues; Hak Choy; Jeffrey Bradley; Kenneth E Rosenzweig; Jeffrey Bogart; Walter J Curran; Elizabeth Gore; Corey Langer; Alexander V Louie; Stephen Lutz; Mitchell Machtay; Varun Puri; Maria Werner-Wasik; Gregory M M Videtic
Journal:  Pract Radiat Oncol       Date:  2015 May-Jun

10.  The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical Research Council Lung Cancer Working Party.

Authors:  R J Stephens; D J Girling; N M Bleehen; K Moghissi; H M Yosef; D Machin
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640
View more
  1 in total

1.  Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio associations with heart and body dose and their effects on patient outcomes in locally advanced non-small cell lung cancer treated with definitive radiotherapy.

Authors:  Wu-Yan Xia; Xue-Ru Zhu; Wen Feng; Jun Liu; Jia-Ming Wang; Chang-Xing Lv; Qin Zhang; Wen Yu; Xu-Wei Cai; Xiao-Long Fu
Journal:  Transl Lung Cancer Res       Date:  2020-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.